Developer docs
API playgroundTry for free, no card

Search company profiles

Virtual Incision

Full company profile

uuid0000bxa

Namestring
Virtual Incision
Legal namestring
Virtual Incision Corporation
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Virtual Incision is a privately held medical device company founded in 2006 and headquartered in Lincoln, Nebraska, that develops miniaturized robotic-assisted surgery (miniRAS) systems. Its flagship product, the MIRA Surgical System, received FDA De Novo authorization in February 2024 for use in colectomy procedures, making it the first FDA-authorized miniaturized robotic-assisted surgery device for soft tissue abdominal procedures. The system is distinguished by a compact ~2-pound form factor and a tray-to-table architecture that does not require the dedicated operating room infrastructure used by mainframe surgical robots; the device runs on NVIDIA Jetson for edge data processing. The portfolio also includes the MIRA IQ data platform, the spaceMIRA variant validated aboard the International Space Station, and the next-generation M2 system in development.

Short descriptiontext

Virtual Incision develops the MIRA Surgical System, the first FDA-authorized miniaturized robotic-assisted surgery platform for soft tissue abdominal procedures, targeting hospitals and surgical settings underserved by mainframe robotic systems.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLincoln, United States
HQ citystring
Lincoln
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
robotic assisted surgery, surgical robotics systems, minimally invasive devices, medical device technology, abdominal surgery robotics
Industry4 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Surgical Robotics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Surgical Robot Hardware Sales
TypeHardware Sales
Description

Sale of MIRA Surgical System devices to hospitals and healthcare facilities for use in robotic-assisted surgery procedures

virtualincision.com
2MIRA IQ Subscription Services
TypeSubscription Recurring
Description

Cloud-based procedure data and analytics platform providing surgeons access to case information and performance metrics

virtualincision.com
3Surgeon Education & Training
TypeProfessional Services
Description

Comprehensive training programs including MIRA Fundamentals Training, proctoring programs, and ongoing surgeon education services

virtualincision.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1MIRA
Description

The world's first miniaturized robotic-assisted surgery (miniRAS) system, designed for use in any operating room with a tray-to-table setup.

virtualincision.com
+2 more records
Core offering1 text field

Virtual Incision develops and manufactures the MIRA Surgical System, the world's first miniaturized robotic-assisted surgery (miniRAS) device. The ~2-pound tray-to-table robot enables soft-tissue abdominal procedures (initially colectomy) in any standard operating room without dedicated infrastructure, complex docking, or specialized draping. The company also offers the MIRA IQ cloud-based procedure data platform, is developing the next-generation M2 system, and provides surgeon training and proctoring services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Virtual Incision offers a unified product portfolio centered on miniaturized robotic-assisted surgery (miniRAS). The core product is the MIRA Surgical System, the world's first FDA-authorized miniaturized surgical robot, designed with a tray-to-table form factor for soft tissue abdominal procedures. The system comprises the MIRA minibot, companion cart, and surgeon console components. Supporting the hardware is MIRA IQ, a cloud-based analytics and procedure data platform. The company is developing the next-generation M2 system and spaceMIRA for space-based telesurgery applications. All products share the common goal of making robotic-assisted surgery accessible to any operating room through miniaturization.

Product and service4 records
1MIRA Surgical System
CategorySurgical robotics - core hardware platform
Description

The world's first miniaturized robotic-assisted surgery (miniRAS) system, designed for soft tissue abdominal procedures. Weighs approximately 2 pounds, features a tray-to-table design that enables setup in minutes without docking or draping in any operating room. The system includes internal triangulation with shoulders, arms, and infinite wrist roll inside the body, an integrated articulating camera, and works through a single incision.

2spaceMIRA
CategorySurgical robotics - space-qualified variant
Description

A space-focused iteration of the MIRA Surgical System designed for testing on the International Space Station. Enables pre-programmed and long-distance remote surgery capabilities for assessing zero-gravity surgical tasks and extreme telesurgery scenarios.

3MIRA IQ
CategoryCloud-based data and analytics platform
Description

Proprietary technology services that allow surgeons and staff to access procedure data and other case information collected during surgical procedures using the MIRA Surgical System. Cloud-based platform for tracking metrics, accessing videos, and gaining surgical insights.

4Surgeon Education & Training
CategoryProfessional services - surgeon training and education
Description

Comprehensive training programs including MIRA Fundamentals Training, proctoring programs, and ongoing surgeon education services that support adoption and effective use of the MIRA Surgical System in hospital and surgical center settings.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-03-18
Description

Virtual Incision announced plans to explore NVIDIA Isaac for Healthcare platform for developing next-generation surgical robotics platforms. Digital twin framework capabilities integrated with robotic learning tools will enable creation of highly realistic virtual environments to simulate surgical details and physiologic processes. The company also continues to explore NVIDIA Cosmos platform for future surgical robot development.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-25
Description

Collaboration to demonstrate preclinical remote robotic-assisted surgery capabilities. Sovato provided surgical-grade network connectivity and clinical workflows for remote procedures spanning nearly 40,000 miles combined distance. Four surgeons performed 20 procedures on porcine models demonstrating remote surgery viability.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-11-25
Description

Partnered for remote surgery demonstration with surgeons Dr. Yuman Fong, Dr. Yanghee Woo, Dr. Yasmin Zerhouni, and Dr. Clayton Lau performing multiple procedure types on porcine models. City of Hope ranked among nation's top 5 cancer centers by U.S. News & World Report.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-11-25
Description

Dr. Francesco Maria Bianco from UIC participated in remote surgery demonstration performing procedures on porcine models alongside City of Hope surgeons.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-07-30
Description

International clinical trial site for MIRA hysterectomy study; Dr. Jean Dubuisson served as principal investigator for first MIRA-assisted hysterectomy procedure.

6NASA
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-30
Description

NASA EPSCoR grant awarded to co-founder Shane Farritor and University of Nebraska for spaceMIRA project. spaceMIRA, a modified version of MIRA, was sent to International Space Station to perform simulated surgical tasks and assess zero-gravity impact on robotic surgery capabilities.

virtualincision.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-30
Description

University of Nebraska-Lincoln collaboration through NASA EPSCoR program for spaceMIRA development. Co-founder Shane Farritor is a faculty member at the university. Researchers leveraged MIRA's design to create space-focused iteration enabling pre-programmed and long-distance remote surgery operation modes.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-30
Description

spaceMIRA was transported to ISS aboard Northrop Grumman Cygnus cargo spacecraft carried by SpaceX Falcon 9 rocket as part of NG-20 mission.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Developer of the Senhance surgical system with digital laparoscopy features and machine vision for instrument tracking. Competes for cost-conscious hospitals seeking alternative robotic platforms with established CE Mark and incremental U.S. adoption.

TypeEmerging player
Description

Public (RBOT) surgical robotics company developing a single-port robotic system with humanoid-like arms for abdominal surgery. Competes in the same miniaturized/portable surgical robotics category targeting hospitals without mainframe RAS access.

TypeBroad incumbent
Description

Launched the Hugo RAS system targeting cost-conscious hospitals and emerging markets, directly competing with MIRA's portability value proposition. Backed by Medtronic's global scale, hospital relationships, and balance sheet to compete for the same underserved-OR segment Virtual Incision targets.

TypeEmerging player
Description

Paris-based startup developing a smaller, bedside surgical robotics assistant designed to complement surgeons in laparoscopic procedures. Comparable miniaturization philosophy and focus on expanding robotic access to outpatient and smaller OR settings.

TypeEmerging player
Description

Swiss developer of the Dexter surgical robot, a compact, modular system designed to bring robotic assistance into any OR without dedicated infrastructure. Closest peer in design philosophy to MIRA, focused on general surgery, gynecology, and urology.

TypeRegional player
Description

China-based subsidiary of MicroPort developing the Toumai laparoscopic surgical robot and other robotic-assisted surgery systems. Represents the regional incumbent competing in the same miniaturized/portable surgical robotics category, primarily serving Asia-Pacific markets.

TypeEmerging player
Description

Houston-based developer of a flexible endoluminal robotic system designed for NOTES (natural orifice transluminal endoscopic surgery) and endoluminal procedures. Adjacent competitor in next-generation minimally invasive robotic approaches for GI surgery.

TypeBroad incumbent
Description

Dominant incumbent in surgical robotics with the da Vinci platform, holding thousands of installed systems and entrenched surgeon training programs globally. Most direct competitor to Virtual Incision across robotic-assisted abdominal surgery, and the benchmark the new CEO (formerly of Intuitive) understands intimately.

TypeBroad incumbent
Description

Developing the Ottava robotic-assisted surgery platform through J&J MedTech (formerly Ethicon), targeting general surgery procedures. Leverages Ethicon's surgical instruments franchise and J&J's massive hospital relationships — directly competing with MIRA's general surgery ambitions.

TypeBroad incumbent
Description

Maker of the Mako robotic-arm assisted surgery system for orthopedic procedures (knee, hip, spine). While in a different surgical specialty, Stryker is a relevant broad incumbent demonstrating the commercial playbook for hospital-based robotic systems and a potential acquirer of cross-specialty robotics platforms.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds15 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors15 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Virtual Incision

Surgical Roboticsvirtualincision.com

Virtual Incision develops the MIRA Surgical System, the first FDA-authorized miniaturized robotic-assisted surgery platform for soft tissue abdominal procedures, targeting hospitals and surgical settings underserved by mainframe robotic systems.

What Virtual Incision does

Virtual Incision is a privately held medical device company founded in 2006 and headquartered in Lincoln, Nebraska, that develops miniaturized robotic-assisted surgery (miniRAS) systems. Its flagship product, the MIRA Surgical System, received FDA De Novo authorization in February 2024 for use in colectomy procedures, making it the first FDA-authorized miniaturized robotic-assisted surgery device for soft tissue abdominal procedures. The system is distinguished by a compact ~2-pound form factor and a tray-to-table architecture that does not require the dedicated operating room infrastructure used by mainframe surgical robots; the device runs on NVIDIA Jetson for edge data processing. The portfolio also includes the MIRA IQ data platform, the spaceMIRA variant validated aboard the International Space Station, and the next-generation M2 system in development.

Virtual Incision firmographics

Firmographics
Name
Virtual Incision
Legal name
Virtual Incision Corporation
Website
https://virtualincision.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Virtual Incision develops the MIRA Surgical System, the first FDA-authorized miniaturized robotic-assisted surgery platform for soft tissue abdominal procedures, targeting hospitals and surgical settings underserved by mainframe robotic systems.
Ownership category
akta.pro rank

Virtual Incision industry classification

Industry
Product category
Surgical Robotics
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Robotic assisted surgery
  • Surgical robotics systems
  • Minimally invasive devices
  • Medical device technology
  • Abdominal surgery robotics

Where Virtual Incision is headquartered

Location

Headquarters

HQ city
Lincoln
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Virtual Incision business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Surgical Robot Hardware Sales: Sale of MIRA Surgical System devices to hospitals and healthcare facilities for use in robotic-assisted surgery procedures
  2. MIRA IQ Subscription Services: Cloud-based procedure data and analytics platform providing surgeons access to case information and performance metrics
  3. Surgeon Education & Training: Comprehensive training programs including MIRA Fundamentals Training, proctoring programs, and ongoing surgeon education services

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Virtual Incision product offering

Product offering

Core offering

Virtual Incision develops and manufactures the MIRA Surgical System, the world's first miniaturized robotic-assisted surgery (miniRAS) device. The ~2-pound tray-to-table robot enables soft-tissue abdominal procedures (initially colectomy) in any standard operating room without dedicated infrastructure, complex docking, or specialized draping. The company also offers the MIRA IQ cloud-based procedure data platform, is developing the next-generation M2 system, and provides surgeon training and proctoring services.

Product overview

Virtual Incision offers a unified product portfolio centered on miniaturized robotic-assisted surgery (miniRAS). The core product is the MIRA Surgical System, the world's first FDA-authorized miniaturized surgical robot, designed with a tray-to-table form factor for soft tissue abdominal procedures. The system comprises the MIRA minibot, companion cart, and surgeon console components. Supporting the hardware is MIRA IQ, a cloud-based analytics and procedure data platform. The company is developing the next-generation M2 system and spaceMIRA for space-based telesurgery applications. All products share the common goal of making robotic-assisted surgery accessible to any operating room through miniaturization.

Differentiator

Problem solved

Functional benefit

Brands

  • MIRA: The world's first miniaturized robotic-assisted surgery (miniRAS) system, designed for use in any operating room with a tray-to-table setup.
  • miniRAS
  • MIRA IQ

Products and services

  • MIRA Surgical System The world's first miniaturized robotic-assisted surgery (miniRAS) system, designed for soft tissue abdominal procedures. Weighs approximately 2 pounds, features a tray-to-table design that enables setup in minutes without docking or draping in any operating room. The system includes internal triangulation with shoulders, arms, and infinite wrist roll inside the body, an integrated articulating camera, and works through a single incision.
  • spaceMIRA A space-focused iteration of the MIRA Surgical System designed for testing on the International Space Station. Enables pre-programmed and long-distance remote surgery capabilities for assessing zero-gravity surgical tasks and extreme telesurgery scenarios.
  • MIRA IQ Proprietary technology services that allow surgeons and staff to access procedure data and other case information collected during surgical procedures using the MIRA Surgical System. Cloud-based platform for tracking metrics, accessing videos, and gaining surgical insights.
  • Surgeon Education & Training Comprehensive training programs including MIRA Fundamentals Training, proctoring programs, and ongoing surgeon education services that support adoption and effective use of the MIRA Surgical System in hospital and surgical center settings.

Companies that use Virtual Incision

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Virtual Incision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature6 records

Virtual Incision partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, major and minor.

  • NVIDIAcoreTechnology or Integration · 18 March 2025Virtual Incision announced plans to explore NVIDIA Isaac for Healthcare platform for developing next-generation surgical robotics platforms. Digital twin framework capabilities integrated with robotic learning tools will enable creation of highly realistic virtual environments to simulate surgical details and physiologic processes. The company also continues to explore NVIDIA Cosmos platform for future surgical robot development.
  • SovatocoreStrategic or Co-development Partner · 25 November 2024Collaboration to demonstrate preclinical remote robotic-assisted surgery capabilities. Sovato provided surgical-grade network connectivity and clinical workflows for remote procedures spanning nearly 40,000 miles combined distance. Four surgeons performed 20 procedures on porcine models demonstrating remote surgery viability.
  • City of Hope National Medical CentermajorStrategic or Co-development Partner · 25 November 2024Partnered for remote surgery demonstration with surgeons Dr. Yuman Fong, Dr. Yanghee Woo, Dr. Yasmin Zerhouni, and Dr. Clayton Lau performing multiple procedure types on porcine models. City of Hope ranked among nation's top 5 cancer centers by U.S. News & World Report.
  • University of Illinois ChicagomajorStrategic or Co-development Partner · 25 November 2024Dr. Francesco Maria Bianco from UIC participated in remote surgery demonstration performing procedures on porcine models alongside City of Hope surgeons.
  • Geneva University HospitalsmajorStrategic or Co-development Partner · 30 July 2024International clinical trial site for MIRA hysterectomy study; Dr. Jean Dubuisson served as principal investigator for first MIRA-assisted hysterectomy procedure.
  • NASAcoreStrategic or Co-development Partner · 30 January 2024NASA EPSCoR grant awarded to co-founder Shane Farritor and University of Nebraska for spaceMIRA project. spaceMIRA, a modified version of MIRA, was sent to International Space Station to perform simulated surgical tasks and assess zero-gravity impact on robotic surgery capabilities.
  • University of NebraskacoreStrategic or Co-development Partner · 30 January 2024University of Nebraska-Lincoln collaboration through NASA EPSCoR program for spaceMIRA development. Co-founder Shane Farritor is a faculty member at the university. Researchers leveraged MIRA's design to create space-focused iteration enabling pre-programmed and long-distance remote surgery operation modes.
  • Northrop Grumman / SpaceXminorStrategic or Co-development Partner · 30 January 2024spaceMIRA was transported to ISS aboard Northrop Grumman Cygnus cargo spacecraft carried by SpaceX Falcon 9 rocket as part of NG-20 mission.

Scale indicators6 records

Recent moves7 records

Expansion highlights7 records

Virtual Incision competitors and assessment

Company assessment

Emerging players

  • Asensus Surgical: Developer of the Senhance surgical system with digital laparoscopy features and machine vision for instrument tracking. Competes for cost-conscious hospitals seeking alternative robotic platforms with established CE Mark and incremental U.S. adoption.
  • Vicarious Surgical: Public (RBOT) surgical robotics company developing a single-port robotic system with humanoid-like arms for abdominal surgery. Competes in the same miniaturized/portable surgical robotics category targeting hospitals without mainframe RAS access.
  • Moon Surgical: Paris-based startup developing a smaller, bedside surgical robotics assistant designed to complement surgeons in laparoscopic procedures. Comparable miniaturization philosophy and focus on expanding robotic access to outpatient and smaller OR settings.
  • Distalmotion: Swiss developer of the Dexter surgical robot, a compact, modular system designed to bring robotic assistance into any OR without dedicated infrastructure. Closest peer in design philosophy to MIRA, focused on general surgery, gynecology, and urology.
  • EndoQuest Robotics: Houston-based developer of a flexible endoluminal robotic system designed for NOTES (natural orifice transluminal endoscopic surgery) and endoluminal procedures. Adjacent competitor in next-generation minimally invasive robotic approaches for GI surgery.

Broad incumbents

  • Medtronic: Launched the Hugo RAS system targeting cost-conscious hospitals and emerging markets, directly competing with MIRA's portability value proposition. Backed by Medtronic's global scale, hospital relationships, and balance sheet to compete for the same underserved-OR segment Virtual Incision targets.
  • Intuitive Surgical: Dominant incumbent in surgical robotics with the da Vinci platform, holding thousands of installed systems and entrenched surgeon training programs globally. Most direct competitor to Virtual Incision across robotic-assisted abdominal surgery, and the benchmark the new CEO (formerly of Intuitive) understands intimately.
  • Johnson & Johnson (Ottava): Developing the Ottava robotic-assisted surgery platform through J&J MedTech (formerly Ethicon), targeting general surgery procedures. Leverages Ethicon's surgical instruments franchise and J&J's massive hospital relationships — directly competing with MIRA's general surgery ambitions.
  • Stryker (Mako): Maker of the Mako robotic-arm assisted surgery system for orthopedic procedures (knee, hip, spine). While in a different surgical specialty, Stryker is a relevant broad incumbent demonstrating the commercial playbook for hospital-based robotic systems and a potential acquirer of cross-specialty robotics platforms.

Regional players

  • MicroPort MedBot: China-based subsidiary of MicroPort developing the Toumai laparoscopic surgical robot and other robotic-assisted surgery systems. Represents the regional incumbent competing in the same miniaturized/portable surgical robotics category, primarily serving Asia-Pacific markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Virtual Incision social profiles

Digital presence

Virtual Incision compliance and trust

Trust signal

Compliance2 records

Virtual Incision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Virtual Incision leadership team

Management profile

Number of profiles

Profiles11 records

Virtual Incision funding detail

Funding detail

Funding overview

Funding rounds15 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Virtual Incision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virtual Incision

What does Virtual Incision do?

Virtual Incision develops and manufactures the MIRA Surgical System, the world's first miniaturized robotic-assisted surgery (miniRAS) device. The ~2-pound tray-to-table robot enables soft-tissue abdominal procedures (initially colectomy) in any standard operating room without dedicated infrastructure, complex docking, or specialized draping. The company also offers the MIRA IQ cloud-based procedure data platform, is developing the next-generation M2 system, and provides surgeon training and proctoring services.

Is Virtual Incision a public or private company?

Virtual Incision is a private company. It is classified as venture growth investor backed and is currently operating.

When was Virtual Incision founded?

Virtual Incision was founded in 2006. It employs 11 to 50 people.

Where is Virtual Incision based?

Virtual Incision is headquartered in Lincoln, United States, in the North America region.

How does Virtual Incision make money?

Three revenue lines are on record. Surgical Robot Hardware Sales are the primary driver. The others are MIRA IQ Subscription Services and surgeon Education & Training.

Who are Virtual Incision's main competitors?

Emerging players on record are Asensus Surgical, Vicarious Surgical, Moon Surgical, Distalmotion and EndoQuest Robotics. Broad incumbents are Medtronic, Intuitive Surgical, Johnson & Johnson (Ottava) and Stryker (Mako). MicroPort MedBot is listed as a regional player.

Does Virtual Incision have an API?

No public API is recorded for Virtual Incision.

What industry is Virtual Incision in?

Virtual Incision's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HDAAAIAC, Healthcare & Assistive Robotics. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SiliconprairienewsQ2 2026 Nebraska venture capital update: Agtech, medtech and robotics continue to raise fundsNebraska saw 14 venture capital deals in Q2 2026, with Marble and Virtual Incision among the highest-raising companies. The deals span agtech, medtech, robotics, and other sectors, with Invest Nebraska and PitchBook tracking the data. Activity is expected to pick up in Q3.NebraskaNational Academy of Inventors honors FarritorShane Farritor, a professor at the University of Nebraska-Lincoln and co-founder of Virtual Incision Corp., has been named a Fellow of the National Academy of Inventors. This recognition highlights his development of surgeon-controlled robots for abdominal surgery, which were recently used in human trials outside the United States to perform colon resections with reduced recovery times. Farritor also holds patents for railroad track integrity sensors licensed by MRail Inc.NebraskaWagner discovers opportunities abound at Nebraska URachael Wagner is completing her master's degree in mechanical engineering at the University of Nebraska–Lincoln, having gained experience through roles at Virtual Incision and Honeybee Robotics. Her work includes developing manufacturing lines for surgical robots undergoing FDA testing and contributing to NASA-funded space technology projects. She is now considering career paths in medical technology, academia, or further research.Medical Device and Diagnostic industryVirtual Incision & NASA to Bring Robotic-Assisted Surgery to SpaceVirtual Incision has been awarded a grant by NASA to test its Mira robotic-assisted surgery platform aboard the International Space Station in 2024. The miniaturized device will perform simulated surgical activities, such as cutting tissue, to evaluate its potential for long-duration space missions.SiliconprairienewsNASA funding supports innovation and research in NebraskaNASA Nebraska Space Grant and EPSCoR programs have provided funding to support STEM education, research, and innovation across 11 colleges and universities in Nebraska, with approximately $800,000 available annually for space grants and student support, plus $250,000 for research infrastructure and $750,000 over three years for national EPSCoR grant winners. Virtual Incision, a Nebraska startup, successfully tested its miniature robotic surgeon on the International Space Station in 2024 after receiving a NASA Nebraska EPSCoR grant awarded to co-founder Shane Farritor and doctoral student Rachael Wagner. The programs connect NASA priorities with Nebraska research in areas including biomechanical, biomedical, robotics, and cancer research, aiming to develop the state's STEM workforce while advancing national space exploration goals.TECH BRIEFSRobots in the Operating RoomVirtual Incision received FDA marketing authorization for its MIRA Surgical System to perform colectomies, shortly after the space-adapted version successfully demonstrated robotic surgery techniques on the International Space Station. The compact, lightweight device was developed with funding from NASA and the U.S. Army to enable minimally invasive procedures in remote or extreme environments.MedTech DiveBuilding a better robot: How Virtual Incision plans to challenge IntuitiveVirtual Incision has appointed former Intuitive Surgical executive Jim Alecxih as CEO to accelerate the development and commercialization of its M2 robotic surgery system. The company is preparing to submit the M2 for FDA review in early 2027, following previous de novo authorization for its predecessor, the MIRA robot. Virtual Incision aims to challenge Intuitive Surgical's market dominance by offering a miniaturized, single-port surgical platform designed for easier adoption in diverse medical settings.OUPblogEnabling Technologies for Remote SurgeryVirtual Incision Corporation and Sovato Health, Inc. successfully demonstrated a remote surgery system using the Miniaturized In Vivo Robotic Assistant (MIRA) across distances up to 2,200 miles in the United States. The platform completed 24 porcine procedures with consistent low latency and high reliability, proving its viability for military medical operations in austere environments.UnemedStartupsUNeMed, the technology transfer organization for the University of Nebraska, supports faculty and students in commercializing university-licensed technologies by helping them form new corporate entities. The article highlights a portfolio of active startups, such as Virtual Incision Corporation and Exavir, which are developing medical devices and pharmaceuticals derived from these innovations.PR Newswirecultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officercultivate(MD), a medical device venture capital firm, announced that its portfolio company Virtual Incision Corporation has appointed Jim Alecxih as Chief Executive Officer. Alecxih, who previously held leadership roles at Intuitive Surgical and served as CEO of DH Medical, brings over 30 years of experience in surgical technology and will lead the company's next-phase development of its M2 miniaturized surgical robotic system. Virtual Incision is preparing for a series of FDA submissions across multiple specialties as it aims to expand access to robotic-assisted surgery in underserved hospital, outpatient, and ambulatory settings worldwide.